A comparison of clinical and pathological features between TD(+) and TD(-) patients revealed that TD(+) patients had higher tumor stages, T stages, and a higher proportion of CEA positivity compared to TD(-) patients, with statistically significant differences (P<0.05). Here, CEACAM5 is linked to neoplasm.